about
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alphaSelective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsPharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampusCocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.A place for the hippocampus in the cocaine addiction circuit: Potential roles for adult hippocampal neurogenesis.Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesityComputational and biological evaluation of N-octadecyl-N'-propylsulfamide, a selective PPARα agonist structurally related to N-acylethanolamines.Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampPlasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidityPharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity.Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain.Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker ratsElaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.Role of the satiety factor oleoylethanolamide in alcoholism.Environmental Enrichment, Age, and PPARα Interact to Regulate Proliferation in Neurogenic Niches.Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat.Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat.Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum.Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals.Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activation.Regulation of brain anandamide by acute administration of ethanolEffects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice.Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.Plasma levels of interleukin-6 and interleukin-18 after an acute physical exercise: relation with post-exercise energy intake in twins.Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif.Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.Hyperplastic obesity and liver steatosis as long-term consequences of suboptimal in vitro culture of mouse embryos.Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents.
P50
Q24319974-D1424920-BFA6-4605-868E-E2875EF6C87CQ24569799-4C1D7722-9844-4519-AE5B-BB279E269AF3Q27318330-D4D420E1-4CCC-4A9E-AB17-72F30FB84695Q30630783-4516F2BD-7E0E-4E6F-8137-0AC1BC3C1569Q31085706-0DB2B646-82A9-43E7-82FC-F84405F2F60DQ33814030-78FB11BA-E993-4A27-BF64-FB924322117CQ35087097-DF13FE26-6DDD-4358-B4A8-453DDA0EA7ABQ35108574-D049EC94-F500-474F-A18F-8652480C93EDQ35126558-24CCDA51-A12A-48A4-BB39-1F4322508F5EQ35132611-0403F77D-B7B8-47BA-9300-790129680D96Q35143914-8216FF08-F0D1-4473-8EA2-6F440D08D769Q35222716-75314977-6F93-4897-B0DF-5E03D5606409Q35532072-28C35C9C-9E46-49FD-8F3C-A4FEDEAA521BQ35636132-EC543736-99A8-4589-997C-BFBE14AF10CAQ35802874-F7B0F839-8060-4561-B459-7E04589AE885Q35815567-FA018F05-AEF9-426E-88CD-53B5BBB3144AQ36103855-E0ADB833-F806-4207-9BA2-882A9A63F00CQ36147328-A58E3958-418E-4DBF-B03F-8CF5D819467FQ36175367-E93FC1C0-3EE5-4B38-A545-040EC653DA24Q36179973-D645564E-1BC6-44EA-8A1C-B981CE8D989BQ36342952-5D24EE91-0D3C-4764-98E0-2DC7AD3E0462Q36665571-488EA2A5-DDAE-4A27-86B4-53AF7AB5E199Q37143602-0ED3306B-BD2E-441B-8F5C-B68E577535D2Q37438534-E2104695-C164-49C5-A6CF-5CE771182387Q37446838-59AC0173-D3EE-424B-9EFB-E377CFE5CBB7Q37618728-CC10F1F5-85B4-44E5-9F11-FD662E168DADQ37686136-8E0B3FAA-55BB-49BF-9DCB-00F9E8E8F45CQ38316712-CC2B8BEA-CBD8-46B5-9A65-A247E6C1989BQ39403052-DE9146BA-F735-4900-9E0B-FC13CC93F04BQ40182413-9F2A2C11-442E-4C88-81F7-F299D9AF691BQ42791197-53C88879-B1AB-4CBE-9848-7123155381A9Q43211015-296608E5-39CC-4B23-B2E1-8D4EF4E2FCE1Q43275192-7A93A41C-E73A-4140-B492-C2DB07704A31Q43617481-6004AC59-02CF-4CF0-AD9F-1AB368796FB3Q43805537-85D9EF2C-2533-4B5F-B3B6-D93BEC2A6674Q43824173-EAE69569-B534-47B5-A143-6024298BF801Q44893640-3202E4E5-EB26-4BEE-93D4-56DD9A4AE3F1Q45909094-9238D168-0E86-4F5F-BB80-C7D23D3F3223Q46172867-634F997E-C65C-416C-9138-A48402EB5BBEQ46295265-8277A780-43DD-4FC7-B592-522A7159BF9F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonia Serrano
@ast
Antonia Serrano
@en
Antonia Serrano
@es
Antonia Serrano
@nl
type
label
Antonia Serrano
@ast
Antonia Serrano
@en
Antonia Serrano
@es
Antonia Serrano
@nl
prefLabel
Antonia Serrano
@ast
Antonia Serrano
@en
Antonia Serrano
@es
Antonia Serrano
@nl
P106
P108
P1153
8854228600
P21
P31
P496
0000-0002-8017-9754